A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NASH

Search Conditions:
Search Keyword : NASH
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: NASH
Appearance Frequency: 6310 time(s)
Long forms: 49

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
nonalcoholic steatohepatitis
(6233 times)
Gastroenterology
(2033 times)
NAFLD (2656 times)
HCC (500 times)
MCD (330 times)
1989 Nonalcoholic steatohepatitis: a study of 49 patients.
non-alcoholic-steato-hepatitis
(7 times)
Cell Biology
(1 time)
NAFLD (4 times)
AFP (1 time)
ALT (1 time)
2006 Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.
NAFLD and steatohepatitis
(5 times)
Food
(2 times)
NAFLD (5 times)
HYF (1 time)
INR (1 time)
2004 Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
non-alcoholic fatty liver disease
(5 times)
Medicine
(2 times)
4-HNE (1 time)
CA (1 time)
CD74 (1 time)
2014 Physiologically realistic and validated mathematical liver model reveals [corrected] hepatobiliary transfer rates for Gd-EOB-DTPA using human DCE-MRI data.
National Audit of Seizure management in Hospitals
(4 times)
Medicine
(1 time)
EDs (2 times)
2015 National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK.
NAFLD can progress to steatohepatitis
(3 times)
Endocrine System Diseases
(1 time)
NAFLD (3 times)
HFD (1 time)
MVs (1 time)
2017 Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
non-alcoholic fatty liver and steatohepatitis
(3 times)
Gastroenterology
(1 time)
APRI (1 time)
FIB-4 (1 time)
HFD (1 time)
2017 Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
nonalcoholic hepatic steatosis and steatohepatitis
(3 times)
Pharmacology
(1 time)
NAFLD (2 times)
ER (1 time)
FABP3 (1 time)
2008 Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
nucleic acid spot hybridization
(3 times)
Biochemistry
(1 time)
PCR (2 times)
BBTD (1 time)
BBTV (1 time)
2009 Detection of Huanglongbing (citrus greening) disease by nucleic acid spot hybridization.
10  nearest accessible specialist hospital
(2 times)
Pulmonary Medicine
(1 time)
NSCLC (2 times)
2014 Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study.
11  non-alcoholic liver disease
(2 times)
Medicine
(1 time)
AI (1 time)
ALD (1 time)
HBV (1 time)
2006 [Non-alcoholic liver disease (NASH)].
12  nonalcoholic hepatitis
(2 times)
Cell Biology
(1 time)
ER (1 time)
NAFLD (1 time)
2016 Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.
13  North Atlantic subtropical high
(2 times)
ISV (1 time)
LLJ (1 time)
SE US (1 time)
2018 Investigating the causes of increased 20th-century fall precipitation over the southeastern United States.
14  encompasses a spectrum from simple steatosis to steatohepatitis
(1 time)
Medicine
(1 time)
DEGs (1 time)
IPA (1 time)
NAFLD (1 time)
2017 Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
15  inflammation and steatohepatisis
(1 time)
Science
(1 time)
NAFLD (1 time)
2010 The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease.
16  NAFLD advancing to steatohepatitis
(1 time)
EVs (1 time)
NAFLD (1 time)
2021 Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact.
17  NAFLD includes fatty liver alone or steatohepatitis
(1 time)
Anatomy
(1 time)
NAFD (1 time)
2002 The clinicopathologic spectrum and management of nonalcoholic fatty liver disease.
18  NAFLD increases the risk of disease progression to steatohepatitis
(1 time)
Endocrinology
(1 time)
DPP-4 (1 time)
GLP-1RAs (1 time)
NAFLD (1 time)
2020 Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease.
19  NAFLD progresses from benign steatosis to steatohepatitis
(1 time)
Biochemistry
(1 time)
ASOs (1 time)
FSP27 (1 time)
NAFLD (1 time)
2017 Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.
20  NAFLD ranges from simple fatty liver to steatohepatitis
(1 time)
Pharmacology
(1 time)
HCC (1 time)
NAFLD (1 time)
2005 The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
21  NAFLD with inflammatory features
(1 time)
Food
(1 time)
BPF (1 time)
CAF (1 time)
IL-6 (1 time)
2018 Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by "Junk Food": Evidence for Anti-Inflammatory Activity.
22  NAFLD, and its more severe form with steatohepatitis
(1 time)
Endocrinology
(1 time)
IR (1 time)
2014 High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
23  NAFLD, but can progress in some patients to advanced steatohepatitis
(1 time)
Gastroenterology
(1 time)
BIA (1 time)
CVD (1 time)
MS (1 time)
2016 Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk.
24  NAFLD, steatosis and steatohepatitis
(1 time)
Biochemistry
(1 time)
NAFLD (1 time)
2010 Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?
25  NAFLD; lowest levels were observed in those with severe steatosis
(1 time)
Diabetes Mellitus
(1 time)
CLA (1 time)
2019 Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?
26  namely steatohepatitis
(1 time)
Gastroenterology
(1 time)
NAFLD (1 time)
2012 Nonalcoholic fatty liver disease in Asia: a story of growth.
27  NASH and advanced fibrosis
(1 time)
Endocrinology
(1 time)
AUCs (1 time)
NAFLD (1 time)
T2DM (1 time)
2019 Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
28  NASH group
(1 time)
Diabetes Mellitus
(1 time)
FPG (1 time)
IFG (1 time)
NAFLD (1 time)
2011 Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis.
29  NASH patients
(1 time)
Gastrointestinal Diseases
(1 time)
LP (1 time)
MTTs (1 time)
NAFLD (1 time)
2014 CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
30  NASH-HCC
(1 time)
Transplantation
(1 time)
HCC (1 time)
LT (1 time)
2018 Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
31  National Alliance for Safe Housing
(1 time)
Spouse Abuse
(1 time)
--- 2021 Identifying and Responding to the Complex Needs of Domestic Violence Housing Practitioners at the Onset of the COVID-19 Pandemic.
32  nations and ranges in severity from steatosis to steatohepatitis
(1 time)
Chemistry
(1 time)
NAFLD (1 time)
Nrf2 (1 time)
ROS (1 time)
2019 Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction.
33  natural, accidental, suicidal, or homicidal
(1 time)
Health Services
(1 time)
HCP (1 time)
2016 Improving the support of the suddenly bereaved.
34  necroinflammatory steatohepatitis
(1 time)
Gastroenterology
(1 time)
CAD (1 time)
miRNAs (1 time)
NAFLD (1 time)
2016 Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.
35  Non Alcoholic Sreatohepatic
(1 time)
Gastroenterology
(1 time)
BMI (1 time)
NAFLD (1 time)
2007 [Frequency of NAFLD in a group of patients with metabolic syndrome in Veracruz, Mexico].
36  Non Alcoholic SteatoHepatopathy
(1 time)
Medicine
(1 time)
--- 2017 [Parietal surgery in the cirrhotic patient. A litterature review].
37  non-acute subdural haematomas
(1 time)
Wounds and Injuries
(1 time)
GOS (1 time)
2019 Factors influencing the results of surgical therapy of non-acute subdural haematomas.
38  non-alcoholic hepatosteatosis
(1 time)
Fibrosis
(1 time)
HSCs (1 time)
2016 Activation of hepatic stellate cell in Pten null liver injury model.
39  non-alcoholic steatohepatitis and cirrhosis
(1 time)
Immune System Diseases
(1 time)
HCC (1 time)
NAFL (1 time)
NAFLD (1 time)
2021 Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.
40  non-Ashkenazi
(1 time)
Allergy and Immunology
(1 time)
AChR (1 time)
ASH (1 time)
MG (1 time)
2017 Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.
41  non-invasive identification of steatohepatitis
(1 time)
Gastroenterology
(1 time)
ION (1 time)
LS (1 time)
NPV (1 time)
2017 Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.
42  non-invasive methods to detect steatohepatitis
(1 time)
Natural Science Disciplines
(1 time)
AUROC (1 time)
GE (1 time)
MR (1 time)
2016 Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.
43  Non-linear Attentional Saturation Hypothesis
(1 time)
Nervous System Diseases
(1 time)
fMRI (1 time)
2018 Network Dynamics of Attention During a Naturalistic Behavioral Paradigm.
44  non-NASH
(1 time)
General Surgery
(1 time)
BMI (1 time)
HCV (1 time)
2018 Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection.
45  non-steatohepatitis
(1 time)
Medicine
(1 time)
NAFLD (1 time)
2020 Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD.
46  nonalcoholic fatty liver diseases and more advanced steatohepatitis
(1 time)
Cell Biology
(1 time)
DKO (1 time)
Prdx4 (1 time)
SOD1 (1 time)
2018 Double Knockout of Peroxiredoxin 4 (Prdx4) and Superoxide Dismutase 1 (Sod1) in Mice Results in Severe Liver Failure.
47  Norwegian summer-autumn spawning herring
(1 time)
Science
(1 time)
NSAH (1 time)
NSSH (1 time)
2017 Oogenesis and reproductive investment of Atlantic herring are functions of not only present but long-ago environmental influences as well.
48  Nutrition and Activity Self-History
(1 time)
Obesity
(1 time)
ReCAP (1 time)
WIC (1 time)
2013 Innovative tools help counselors discuss childhood obesity with parents.
49  only a small proportion of these patients develop steatohepatitis
(1 time)
Gastroenterology
(1 time)
Hh (1 time)
2012 Mechanisms of disease progression in NASH: new paradigms.